Table 4.

Tumor-infiltrating lymphocyte (TIL) infusion characteristics.

Patient number	Days until infusion	Fold expansion	No. of TIL infused	Viability (%)	%CD4	%CD8
1	45	1,733	1.04E + 11	88.4	4	96
2	52	1,453	8.72E + 10	92.5	4	96
3	53	1,002	6.01E + 10	91.3	26	73
4	45	1,560	9.36E + 10	82.0	3	97
5	45	935	5.61E + 10	84.7	31	70
6	46	1,617	9.70E + 10	88.6	73	27
7	59	1,405	8.43E + 10	93.7	2	98
8	39	1,218	6.96E + 10	91	3	97
9	77	900	5.40E + 10	90.1	2	99
10	53	558	3.35E + 10	92.2	53	44
11	53	382	2.29E + 10	86.2	34	56
12	40	665	3.99E + 10	90.3	41	54
13	Not treated	Not treated	Not treated	Not treated	Not treated	Not treated
Mean	50.6	1,119	6.68E + 10	89.3	23.0	75.6